4//SEC Filing
KAYSEN DAVID B 4
Accession 0001437749-18-011850
CIK 0001029125other
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 5:20 PM ET
Size
6.6 KB
Accession
0001437749-18-011850
Insider Transaction Report
Form 4
KAYSEN DAVID B
President and CEO
Transactions
- Purchase
Common Stock
2018-05-16+1,000→ 51,000 total - Purchase
Warrant (right to buy)
2018-05-16+1,000→ 1,000 totalExercise: $5.00From: 2018-05-16Exp: 2021-05-16→ Common Stock (1,000 underlying)
Footnotes (1)
- [F1]Reflects purchase of 1,000 units from the issuer at a price equal to $5.00 per unit. Each unit consisted of one share of common stock and a warrant to purchase an additional share of common stock.
Documents
Issuer
Sun BioPharma, Inc.
CIK 0001029125
Entity typeother
Related Parties
1- filerCIK 0001133026
Filing Metadata
- Form type
- 4
- Filed
- Jun 13, 8:00 PM ET
- Accepted
- Jun 14, 5:20 PM ET
- Size
- 6.6 KB